These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11698694)

  • 1. Anti-HIV effects of chloroquine: mechanisms of inhibition and spectrum of activity.
    Savarino A; Gennero L; Chen HC; Serrano D; Malavasi F; Boelaert JR; Sperber K
    AIDS; 2001 Nov; 15(17):2221-9. PubMed ID: 11698694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The anti-HIV-1 activity of chloroquine.
    Savarino A; Gennero L; Sperber K; Boelaert JR
    J Clin Virol; 2001 Feb; 20(3):131-5. PubMed ID: 11166661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 dual/mixed tropic isolates show different genetic and phenotypic characteristics and response to maraviroc in vitro.
    Svicher V; Balestra E; Cento V; Sarmati L; Dori L; Vandenbroucke I; D'Arrigo R; Buonomini AR; Van Marck H; Surdo M; Saccomandi P; Mostmans W; Aerssens J; Aquaro S; Stuyver LJ; Andreoni M; Ceccherini-Silberstein F; Perno CF
    Antiviral Res; 2011 Apr; 90(1):42-53. PubMed ID: 21349294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of HIV-1 replication by hydroxychloroquine: mechanism of action and comparison with zidovudine.
    Chiang G; Sassaroli M; Louie M; Chen H; Stecher VJ; Sperber K
    Clin Ther; 1996; 18(6):1080-92. PubMed ID: 9001825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent, broad-spectrum inhibition of human immunodeficiency virus type 1 by the CCR5 monoclonal antibody PRO 140.
    Trkola A; Ketas TJ; Nagashima KA; Zhao L; Cilliers T; Morris L; Moore JP; Maddon PJ; Olson WC
    J Virol; 2001 Jan; 75(2):579-88. PubMed ID: 11134270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyanionic (i.e., polysulfonate) dendrimers can inhibit the replication of human immunodeficiency virus by interfering with both virus adsorption and later steps (reverse transcriptase/integrase) in the virus replicative cycle.
    Witvrouw M; Fikkert V; Pluymers W; Matthews B; Mardel K; Schols D; Raff J; Debyser Z; De Clercq E; Holan G; Pannecouque C
    Mol Pharmacol; 2000 Nov; 58(5):1100-8. PubMed ID: 11040059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The differential binding and activity of PRO 2000 against diverse HIV-1 envelopes.
    Sachdev DD; Zerhouni-Layachi B; Ortigoza M; Profy AT; Tuen M; Hioe CE; Klotman ME
    J Acquir Immune Defic Syndr; 2009 Jun; 51(2):125-9. PubMed ID: 19349871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent anti-HIV (type 1 and type 2) activity of polyoxometalates: structure-activity relationship and mechanism of action.
    Witvrouw M; Weigold H; Pannecouque C; Schols D; De Clercq E; Holan G
    J Med Chem; 2000 Mar; 43(5):778-83. PubMed ID: 10715146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chloroquine exerts an additive in vitro anti-HIV type 1 effect when associated with didanosine and hydroxyurea.
    Boelaert JR; Sperber K; Piette J
    AIDS Res Hum Retroviruses; 1999 Sep; 15(14):1241-7. PubMed ID: 10505672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble gC1q-R/p33, a cell protein that binds to the globular "heads" of C1q, effectively inhibits the growth of HIV-1 strains in cell cultures.
    Szabó J; Cervenák L; Tóth FD; Prohászka Z; Horváth L; Kerekes K; Beck Z; Bácsi A; Erdei A; Peerschke EI; Füst G; Ghebrehiwet B
    Clin Immunol; 2001 May; 99(2):222-31. PubMed ID: 11318594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of chloroquine on reducing HIV-1 replication in vitro and the DC-SIGN mediated transfer of virus to CD4+ T-lymphocytes.
    Naarding MA; Baan E; Pollakis G; Paxton WA
    Retrovirology; 2007 Jan; 4():6. PubMed ID: 17263871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the antiretroviral effects of a PEG-conjugated peptide derived from human CD38.
    Bensi T; Mele F; Ferretti M; Norelli S; El Daker S; Chiocchetti A; Maria Rojo J; Cauda R; Dianzani U; Savarino A
    Expert Opin Ther Targets; 2009 Feb; 13(2):141-52. PubMed ID: 19236233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120.
    Derdeyn CA; Decker JM; Sfakianos JN; Wu X; O'Brien WA; Ratner L; Kappes JC; Shaw GM; Hunter E
    J Virol; 2000 Sep; 74(18):8358-67. PubMed ID: 10954535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel phorbol esters exert dichotomous effects on inhibition of HIV-1 infection and activation of latent HIV-1 expression.
    Zhong Y; Matsuya Y; Nemoto H; Mori M; Saito H; Yamamoto N
    Antivir Chem Chemother; 2005; 16(5):303-13. PubMed ID: 16245646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variable sensitivity of CCR5-tropic human immunodeficiency virus type 1 isolates to inhibition by RANTES analogs.
    Torre VS; Marozsan AJ; Albright JL; Collins KR; Hartley O; Offord RE; Quiñones-Mateu ME; Arts EJ
    J Virol; 2000 May; 74(10):4868-76. PubMed ID: 10775626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular high mobility group box-1 inhibits R5 and X4 HIV-1 strains replication in mononuclear phagocytes without induction of chemokines and cytokines.
    Cassetta L; Fortunato O; Adduce L; Rizzi C; Hering J; Rovere-Querini P; Bianchi ME; Alfano M; Poli G
    AIDS; 2009 Mar; 23(5):567-77. PubMed ID: 19194273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-HIV effects of chloroquine: inhibition of viral particle glycosylation and synergism with protease inhibitors.
    Savarino A; Lucia MB; Rastrelli E; Rutella S; Golotta C; Morra E; Tamburrini E; Perno CF; Boelaert JR; Sperber K; Cauda R
    J Acquir Immune Defic Syndr; 2004 Mar; 35(3):223-32. PubMed ID: 15076236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-momorcharin inhibits HIV-1 replication in acutely but not chronically infected T-lymphocytes.
    Zheng YT; Ben KL; Jin SW
    Zhongguo Yao Li Xue Bao; 1999 Mar; 20(3):239-43. PubMed ID: 10452099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secreted phospholipases A(2), a new class of HIV inhibitors that block virus entry into host cells.
    Fenard D; Lambeau G; Valentin E; Lefebvre JC; Lazdunski M; Doglio A
    J Clin Invest; 1999 Sep; 104(5):611-8. PubMed ID: 10487775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms involved in stimulation of human immunodeficiency virus type 1 replication by aminooxypentane RANTES.
    Marozsan AJ; Torre VS; Johnson M; Ball SC; Cross JV; Templeton DJ; Quiñones-Mateu ME; Offord RE; Arts EJ
    J Virol; 2001 Sep; 75(18):8624-38. PubMed ID: 11507208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.